What is the translation of " G- CSF " in English?

• G-CSF

Examples of using G- CSF in Danish and their translations into English

G- CSF, eller at dosisreducere af hensyn til neutrofiltallet.
G-CSF or to dose reduce to maintain neutrophil counts.

Patienterne blev behandlet uden præmedicinering med steroider eller planlagt G- CSF støtte.
Patients were treated without steroid pre- treatment or planned G-CSF support.

G- CSF mod neutropeni samt transfusioner mod anæmi eller trombocytopeni, efter behov.
G-CSF for neutropenia and transfusions for anaemia or thromobocytopenia as required.

Patienter bør modtage terapeutisk G- CSF så snart som muligt efter overdosering er erkendt.
Patients should receive therapeutic G-CSF as soon as possible after discovery of overdose.

G- CSF blev anvendt som sekundær profylakse hos 19, 3% af patienterne 10, 7% af cyklus.
G-CSF was used for secondary prophylaxis in 19.3% of patients 10.7% of the cycles.

I undersøgelsen fik hovedparten af patienterne administreret granulocytkoloni stimulerende faktor G- CSF.
In the study, the majority of patients were administered granulocyte colony stimulating factor G-CSF.

Profylaktisk G- CSF kan anvendes til at nedsættes risikoen for hæmatologiske toksiciteter.
Prophylactic G-CSF may be used to mitigate the risk of hematological toxicities.

Behandlingscyklerne var hver 3. uge i hver enkelt undersøgelse og der blev anvendt G- CSF i 38- 56% af cyklerne.
Treatment cycles were every three weeks in each trial and G-CSF was used in 38-56% of the cycles.

Derudover har G- CSF vist sig at øge neutrofil migration gennem det vaskulære endotel.
Additionally, G-CSF has been shown to increase neutrophil migration across the vascular endothelium.

Der er rapporteret sjældne pulmonale bivirkninger, især interstitiel pneumoni, efter administration af G- CSF.
Rare pulmonary undesirable effects, in particular interstitial pneumonia, have been reported after G- CSF administration.

Dermed har G- CSF vist sig at inducere endotelcellefunktioner i forbindelse med angiogenese.
Accordingly, G-CSF has been shown to induce endothelial cell functions related to angiogenesis.

Rekombinant- methionyl humant granulocyt- kolonistimulerende faktor(G- CSF) fremstillet i E. coli ved rekombinant DNA- teknologi.
Recombinant methionylated human granulocyte-colony stimulating factor(G-CSF) produced in E. coli by recombinant DNA technology.

Humant G- CSF er et glykoprotein, som regulerer dannelsen og frigivelsen af funktionelle neutrofiler fra knoglemarven.
Human G-CSF is a glycoprotein which regulates the production and release of functional neutrophils from the bone marrow.

Havde denne reaktion, skulle forblive på G- CSF og have deres docetaxel- dosis reduceret til 60 mg/ m2.
Patients who continued to experience this reaction should remain on G-CSF and have their docetaxel dose reduced to 60 mg/ m².

Humant G- CSF er et glycoprotein, der regulerer dannelse og frigivelse af funktionelle neutrofile granulocytter fra knoglemarven.
Human G-CSF is a glycoprotein which regulates the production and release of functional neutrophils from the bone marrow.

Som andre hæmatopoietiske vækstfaktorer har G- CSF udvist in vitro- stimulerende egenskaber i humane endotelceller.
As with other haematopoietic growth factors, G-CSF has shown in vitro stimulating properties on human endothelial cells.

Det aktive stof i Zarzio, filgrastim, svarer i høj grad til et humant protein kaldet granulocyt kolonistimulerende faktor G- CSF.
The active substance in Zarzio, filgrastim, is very similar to a human protein called granulocyte colony stimulating factor G-CSF.

Donorer, der får G- CSF til mobilisering af perifere blodstamceller, skal monitoreres, indtil deres hæmatologiske værdier atter er normale.
Donors who receive G-CSFs for PBPC mobilisation should be monitored until haematological indices return to normal.

Febril neutropeni og neutropenisk infektion forekom hos respektivt 17, 2% og 13, 5% af patienterne, uanset anvendelse af G- CSF.
Blood and lymphatic system disorders Febrile neutropenia and neutropenic infection occurred in 17.2% and 13.5% of patients respectively, regardless of G-CSF use.

Man bør anvende profylaktisk G- CSF for at nedsætte risikoen for hæmatologisk toksicitet se også” Dosisjustering under behandling”.
Prophylactic G-CSF should be used to mitigate the risk of hematological toxicities see also Dose adjustments during treatment.

Det kunstigt fremstillede middel virker på samme måde som det naturligt fremstillede G- CSF ved at tilskynde knoglemarven til at producere flere hvide blodlegemer.
The replacement acts in same way as naturally produced G-CSF by encouraging the bone marrow to produce more white blood cells.

G- CSF kan fremme vækst af myeloide celler, også maligne celler, in vitro og lignende effekter kan ses på nogle ikke- myeloide celler in vitro.
G-CSF can promote growth of myeloid cells, including malignant cells, in vitro and similar effects may be seen on some non-myeloid cells in vitro.

Det gælder især for:• Vækstfaktorer, fx G- CSF, fordi din læge skal stoppe med denne behandling 2 uger, før du skal have Zevalin.
This includes especially:• growth factor such as G-CSF, as your doctor should interrupt this therapy already(two weeks) before giving you Zevalin.

Det tilhører en gruppe proteiner ved navn cytokiner og ligner meget den granulocyt- kolonistimulerende faktor(G- CSF), som kroppen selv producerer.
It belongs to a group of proteins called cytokines, and is very similar to the granulocyte-colony stimulating factor(G-CSF) produced by the human body.

Human granulocyt- kolonistimulerende faktor(G- CSF) er et glykoprotein, der regulerer produktionen og afgivelsen af neutrofile granulocytter fra knoglemarven.
Human granulocyte colony stimulating factor(G-CSF) is a glycoprotein, which regulates the production and release of neutrophils from the bone marrow.

Tasigna kan gives i kombination med hæmatopoietiske vækstfaktorer som erythropoietin eller granulocytkoloni- stimulerende faktor(G- CSF), hvis dette er klinisk indiceret.
Tasigna may be given in combination with haematopoietic growth factors such as erythropoietin or granulocyte colony-stimulating factor(G-CSF) if clinically indicated.

G- CSF blev administreret som sekundær profylakse til patienter, som fik kompliceret neutropeni febril neutropeni, forlænget neutropen eller infektion.
G-CSF was administered as secondary prophylaxis to patients who experienced complicated neutropenia febrile neutropenia, prolonged neutropenia, or infection.

Patienter i behandling med TCF bør have profylaktisk G- CSF for at nedsætte risikoen for kompliceret neutropeni febril neutropeni, prolongeret neutropeni eller neutropenisk infektion.
Patients treated with TCF should receive prophylactic G-CSF to mitigate the risk of complicated neutropenia febrile neutropenia, prolonged neutropenia or neutropenic infection.

Der er rapporteret om almindelige, men generelt symptomfri tilfælde af splenomegali og meget sjældne tilfælde af miltruptur hos raske donorer og patienter efter administration af G- CSF.
Common but generally asymptomatic cases of splenomegaly and very rare cases of splenic rupture have been reported in healthy donors and patients following administration of G-CSFs.

Febril neutropeni og neutropenisk infektion forekom respektivt hos 12, 1% og 3, 4% af patienterne, når patienterne modtog profylaktisk G- CSF, hos 15, 6% og 12, 9% af patienterne uden profylaktisk G- CSF se punkt 4. 2.
Febrile neutropenia and neutropenic infection occurred respectively in 12.1% and 3.4% of patients when patients received prophylactic G-CSF, in 15.6% and 12.9% of patients without prophylactic G-CSF see section 4.2.